story of the week
Safety and Efficacy of Pembrolizumab, Radiation Therapy, and Surgery in Patients With Stage III Soft Tissue Sarcoma of the Extremity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial
Lancet 2024 Nov 23;404(10467)2053-2064, YM Mowery, KV Ballman, AM Hong, SM Schuetze, AJ Wagner, V Monga, RS Heise, S Attia, E Choy, MA Burgess, S Bae, DI Pryor, BA Van Tine, G Tinoco, B Chmielowski, C Freeman, A Gronchi, CF Meyer, MA Dickson, L Hartner, LE Davis, BC Powers, EJ Moding, KJ Weinhold, M van de Rijn, BE Brigman, RF Riedel, DG KirschFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.